nOPV2 (oral polio vaccine) / Bio Farma Indonesia - LARVOL DELTA

Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines (clinicaltrials.gov) - P1/2 | N=2400 | Recruiting | Sponsor: PATH | Not yet recruiting ➔ Recruiting

Enrollment open • Infectious Disease

A Study to Evaluate Pharyngeal Immunity to Poliovirus Type-2 (clinicaltrials.gov) - P4 | N=500 | Completed | Sponsor: Fidec Corporation | Active, not recruiting ➔ Completed

Trial completion • Infectious Disease

Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines (clinicaltrials.gov) - P1/2 | N=2400 | Not yet recruiting | Sponsor: PATH | Trial completion date: Dec 2025 ➔ Dec 2027 | Initiation date: Dec 2023 ➔ Mar 2025 | Trial primary completion date: Dec 2025 ➔ Dec 2027

Trial completion date • Trial initiation date • Trial primary completion date • Infectious Disease

A Study to Evaluate Pharyngeal Immunity to Poliovirus Type-2 (clinicaltrials.gov) - P4 | N=500 | Active, not recruiting | Sponsor: Fidec Corporation | Recruiting ➔ Active, not recruiting

Enrollment closed • Infectious Disease

A Study to Evaluate Pharyngeal Immunity to Poliovirus Type-2 (clinicaltrials.gov) - P4 | N=500 | Recruiting | Sponsor: Fidec Corporation | Not yet recruiting ➔ Recruiting

Enrollment open • Infectious Disease